Download this Executive Summary to Learn More
As clinical trials grow increasingly decentralised and patient-centric, traditional clinical supply chains often fall short. This shift is driven by the increasing complexity of therapies, the need for faster market entry, and a focus on sustainability. This executive summary evaluates clinical supply models and introduces FastChain®, Catalent’s demand-led decentralized model that aligns supply with real-time patient needs. With scalable, on-demand clinical supply solutions, sponsors can reduce drug overage and waste and accelerate study start-up across global regions. Specialized case management combined with demand-led clinical supply, are ideal for temperature-sensitive and high value investigational therapies.
Learn more about:
- How demand-led supply models reduce overage and support rapid country activation.
- Combining flexible supply strategies with specialist case management to increase speed, flexibility, and global patient access for complex clinical programs.
- Real‑world case studies where sponsors used FastChain® demand-led supply for measurable cost, speed, and efficiency impact.
Offered Free by: Catalent Pharma Services
See All Resources from: Catalent Pharma Services
